- Tweeter
republish
After the takeover in 2018 of the American giant pesticides Monsanto, the German company is facing criticism from all sides. Trials in the United States have cost him dearly and his image is very negative.
With our correspondent in Berlin, Pascal Thibaut,
Dead bees tramped by Bayer shareholders, young environmental advocates of " Fridays for future " shouting " we are here, we make noise because you steal our future ". Already outside, the general assembly of Bayer was tumultuous, Friday, April 26th.
Inside, shareholders have said all the harm they thought of the group's management, whose stock price has fallen by nearly 40% since the acquisition of Monsanto. " In two years, Bayer, the pharmaceutical giant has become a dwarf " summarizes the head of the fund managed by the German savings banks.
Bayer boss Werner Baumann acknowledged that the takeover of US giant pesticides and GMOs Monsanto had a negative impact on Bayer. The company was twice sentenced to heavy compensation in connection with Monsanto's flagship product, glyphosate, which is known to be carcinogenic.
More than 13,000 claims against this product have been filed in the United States. However, Werner Baumann is optimistic and hopes to win on appeal. He remains convinced of the certainty of glyphosate and defends the economic relevance of this historic acquisition for $ 63 billion.
► See also: Glyphosate in five questions